To verify whether the mRNA expression of targeted molecules is associated with the effectiveness of molecular targeted drugs, mRNA expression of sorafenib-target genes VEGFR, PDGFRβ, and c-Raf and in vitro sorafenib sensitivity were investigated in HCC cell lines. The gene discussed is RAF1; the disease is hepatocellular carcinoma.